Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Suitors ideas
View:
Post by Trogarzon on Dec 30, 2022 2:46pm

Suitors ideas

I always watck a small comapny called Knight Pharmaceutical in Montreal, they have over 100M in cash and 200M + in sales.  Wonder if they could take a shot at Thera with it's accrued losses and free pipeline atm.
Comment by smallcapinv on Dec 30, 2022 5:20pm
Unlikely. They are not an early stage development company and very likely never will be.  I don't believe that US is a priority for them. They have a strong mgmt team that know what they are doing.  Let's recap situation: minimal progress with oncology, NASH seems like a pipe dream. Ditched European platform and most of growth in Trogarzo and Egrifta is coming from price ...more  
Comment by LouisW on Dec 30, 2022 11:14pm
We have to post based on the truth. "most of growth in Trogarzo and Egrifta is coming from price increases in US" Is this real? Only 3% price increase implemented in this year and until 2022Q3, the sale increases approximately 15%
Comment by Trogarzon on Dec 31, 2022 10:42am
Yes that is the truth and it should  be enough to cover the interest on tthe 40M usd dept we incured for Nash and Th1902 now valued at 0$.  I don't even know what's the next milestone now.   Why do you even bother to buy a stock like this.  The analyst with 6usd to 9usd targets  are 600% and 900% away from their targets... maybe they changed 12 month for 12 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities